Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocosol Paclitaxel in 2nd Line Urothelial Carcinoma
NCT00034177Phase 2Completed
- Sponsor
- Achieve Life Sciences
- Start
- Apr 2002
- Primary completion
- Sep 2007
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in transitional cell carcinoma of the urothelium (TCC), sponsored by Achieve Life Sciences. Primary endpoints: Objective Response Rate, Time to Disease Progression and 4 more. Started Apr 2002; status: completed.
02
Drugs
paclitaxel
03
Conditions
transitional cell carcinoma of the urothelium (TCC)
Beyond the preview
Go deeper on NCT00034177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00034177.